Under the terms of the agreement, Biogen will make an upfront payment of US $ 8 million to Xbrane
The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer
Pfizer is evaluating the FDA’s comments and will work with the agency to determine an appropriate path forward
Trastuzumab is monoclonal antibody used to treat human epidermal growth factor receptor 2 positive (HER2+) breast cancer and metastatic gastric cancers
Immatics to receive upfront payment of US $ 150 million and additional milestone payments of up to US $ 770 million plus tiered double-digit royalties on net product sales
These results demonstrate the potential benefits of heterologous boosting (mix-and-match). The article describing these results have been posted on medRxiv
The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease
The union health ministry notifies the protocol and this move will also help in organ donation
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma
Subscribe To Our Newsletter & Stay Updated
